Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

SCYNEXIS Q2 EPS $(0.22) Up From $(0.64) YoY

SCYNEXIS (NASDAQ:SCYX) reported quarterly losses of $(0.22) per share. This is a 65.63 percent increase over losses of $(0.64) per share from the same period last year.

byBill Haddad

August 16, 2021

1 minute read

SCYNEXIS (NASDAQ:SCYX) reported quarterly losses of $(0.22) per share. This is a 65.63 percent increase over losses of $(0.64) per share from the same period last year.

Deutsche Bank Maintains Buy on ModivCare, Lowers Price Target to $150

By Benzinga Newsdesk

Today, 6:00 AM

Deutsche Bank analyst Pito Chickering maintains ModivCare (NASDAQ:MODV) with a Buy and lowers the price target from $180 to $150.

MODV

‘Pennsylvania Psilocybin Research Bill In Limbo After Key Committee Chair Raises Concern Over Mushroom ‘Overdose,’ Sponsor Says’ -Marijuana Moment Report

By Benzinga Newsdesk

Today, 6:00 AM

https://www.marijuanamoment.net/pennsylvania-psilocybin-research-bill-in-limbo-after-key-committee-chair-raises-concern-over-mushroom-overdose-sponsor-says/

CMPS